TNF and Alzheimer disease: Pearson’s correlation analyses of baseline levels of TNF-α found higher baseline levels of TNF-α associated with longitudinal changes in ADAS-Cog13 over a year (r = −0.2453, p = 0.0471) in patients with AD (Figure 3).